Free shipping on all orders over $ 500

Relacorilant

Cat. No. M11555
Relacorilant Structure
Synonym:

CORT 125134

Size Price Availability Quantity
5mg USD 300  USD300 In stock
10mg USD 450  USD450 In stock
25mg USD 780  USD780 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Relacorilant is a selective, oral bioeffective glucocorticoid receptor antagonist (Ki of 7.2 nM in HepG2 TAT assay and 12,81.2 nM in rat, human and monkey glucocorticoid receptor in cell-based assay). Relacorilant can be used in studies of Cushing's syndrome.

Chemical Information
Molecular Weight 586.56
Formula C27H22F4N6O3S
CAS Number 1496510-51-0
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Rosario Pivonello, et al. Front Endocrinol (Lausanne). Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

[2] Andrew E Greenstein, et al. Oncotarget. Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells

[3] Rosario Pivonello, et al. Front Endocrinol (Lausanne). Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials

[4] Joseph M Custodio, et al. J Clin Pharmacol. An In Vitro and In Vivo Evaluation of the Effect of Relacorilant on the Activity of Cytochrome P450 Drug Metabolizing Enzymes

[5] Richard A Feelders, et al. Lancet Diabetes Endocrinol. Advances in the medical treatment of Cushing's syndrome

Related GCR Products
ORIC-101

ORIC-101 is a potent and selective glucocorticoid receptor antagonist with an EC50 value of 5.6 nM and anticancer activity.

Mometasone Furoate Monohydrate

Mometasone Furoate Monohydrate is a glucocorticoid receptor agonist with anti-inflammatory and anti-allergic activity.

RU 26988

RU 26988 is a highly specific glucocorticoid receptor agonist.

HP210

HP210 is a selective glucocorticoid receptor modulator (SGRM).

Glucocorticoid receptor modulator 2

Glucocorticoid receptor modulator 2 is a glucocorticoid receptor modulator, with an IC50 value less than 100 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Relacorilant, CORT 125134 supplier, GCR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.